Body composition in chronic kidney disease

Current Opinion in Nephrology and Hypertension

Volumn 24, Issue 3, 2015, Pages 268-275

  Johansen, Kirsten L ^a   Lee, Carol ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

frailty; obesity; physical function; sarcopenia; visceral fat

Indexed keywords

ADIPONECTIN; ANDROGEN; CREATININE; INTERLEUKIN 6; LEPTIN; OXYMETHOLONE; TUMOR NECROSIS FACTOR ALPHA;

BODY COMPOSITION; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CORONARY ARTERY CALCIFICATION; CREATININE URINE LEVEL; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; END STAGE RENAL DISEASE; FAT FREE MASS; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HUMAN; INTRAABDOMINAL FAT; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; OBESITY; PHYSICAL PERFORMANCE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SARCOPENIA; SURVIVAL; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; COMPLICATION; HEMODIALYSIS; METABOLISM; MORTALITY; PHYSIOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC;

ADIPOSITY; BODY COMPOSITION; BODY MASS INDEX; HUMANS; OBESITY; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84928496831     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000120     Document Type: Review

References (61)

1. Eknoyan G. Adolphe Quetelet (1796-1874): the average man and indices of obesity. Nephrol Dial Transplant 2008; 23:47-51.
2. Carrero JJ. Misclassification of obesity in CKD: appearances are deceptive. Clin J Am Soc Nephrol 2014; 9:2025-2027.
3. Keys A, Fidanza F, Karvonen MJ, et al. Indices of relative weight and obesity. J Chronic Dis 1972; 25:329-343.
4. WHO Expert Committee on Physical Status. WHO Expert Committee on Physical Status: the use and interpretation of anthropometry. Geneva: World Health Organization; 1995. Contract No.: WHO technical report series 854.
5. Kopple JD, Zhu X, Lwe NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999; 56:1136-1148.
6. Johansen KL, Young B, Kaysen GA, Chertow GM. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004; 80:324-332.
7. Leavey S, Strawderman R, Jones C, et al. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998; 31:997-1006.
8. Port F, Ashby V, Dhingra R, et al. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13:1061-1066.
9. Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 2006; 17:1453-1459.
10. Johansen KL. Obesity and body composition for transplant wait-list candidacy: challenging or maintaining the BMI limits? J Renal Nutr 2013; 23:207-209.
11. Gracia-Iguacel C, Qureshi AR, Avesani CM, et al. Subclinical versus overt obesity in dialysis patients: more than meets the eye. Nephrol Dial Transplant 2013; 28 (Suppl 4):iv175-iv181.
12. Lu JL, Kalantar-Zadeh K, Ma JZ, et al. Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol 2014; 25:2088-2096.
13. Pieloch D, Dombrovskiy V, Osband AJ, et al. Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantation. J Renal Nutr 2014; 24:50-57.
14. Ahmadi SF, Zahmatkesh G, Streja E, et al. Body mass index and mortality in kidney transplant recipients: a systematic review and meta-analysis. Am J Nephrol 2014; 40:315-324.
15. Molnar MZ, Streja E, Kovesdy CP, et al. Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant 2011; 11:725-736.
16. Kalantar-Zadeh K, Kuwae N, Wu DY, et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 2006; 83:202-210.
17. Cabezas-Rodriguez O, Carrero JJ, Zoccali C, et al. Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. Clin J Am Soc Nephrol 2013; 8:1725-1733.
18. Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 2008; 18:388-395.
19. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008; 11:693-700.
20. Martinson M, Ikizler TA, Morrell G, et al. Associations of body size and body composition with functional ability and quality of life in hemodialysis patients. Clin J Am Soc Nephrol 2014; 9:1082-1090.
21. Johansen KL, Dalrymple LS, Delgado C, et al. Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. J Am Soc Nephrol 2014; 25:381-389.
22. Delgado C, Doyle JW, Johansen KL. Association of frailty with body composition among patients on hemodialysis. J Renal Nutr 2013; 23:356-362.
23. Adamczak M, Wiecek A. The adipose tissue as an endocrine organ. Semin Nephrol 2013; 33:2-13.
24. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol 2006; 64:355-365.
25. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13:134-141.
26. Ohashi N, Kato A, Misaki T, et al. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients. Intern Med 2008; 47:485-491.
27. El-Shafey EM, Shalan M. Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients. Ther Apher Dial 2014; 18:185-192.
28. Zoccali C, Postorino M, Marino C, et al. Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. J Intern Med 2011; 269:172-181.
29. Bazanelli AP, Kamimura MA, Canziani MEF, et al. Waist circumference as a predictor of adiponectin levels in peritoneal dialysis patients: a 12-month follow-up study. Perit Dial Int 2013; 33:182-188.
30. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005; 165:777-783.
31. Aoqui C, Cuppari L, Kamimura MA, Canziani MEF. Increased visceral adiposity is associated with coronary artery calcification in male patients with chronic kidney disease. Eur J Clin Nutr 2013; 67:610-614.
32. Kamimura MA, Carrero JJ, Canziani MEF, et al. Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients. Nutr Metab Cardiovasc Dis 2013; 23:891-897.
33. Cordeiro AC, Qureshi AR, Lindholm B, et al. Visceral fat and coronary artery calcification in patients with chronic kidney disease. Nephrol Dial Transplant 2013; (28 Suppl 4):iv152-iv159.
34. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73:391-398.
35. Johansen KL, Shubert T, Doyle J, et al. Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. Kidney Int 2003; 63:291-297.
36. International Working Group on Sarcopenia. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. J Am Med Dir Assoc 2011; 12:249-256.
37. Evans WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr 1993; 123 (2 Suppl):465-468.
38. Cruz-Jentof AJ, Baeyns JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39:412-423.
39. Foley RN, Wang C, Ishani A, et al. Kidney function and sarcopenia in the United States general population: NHANES II. Am J Nephrol 2007; 27:279-286.
40. Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr 2014; 33:64-68.
41. Rosenberger J, Kissova V, Majernikova M, et al. Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality. J Renal Nutr 2014; 24:172-176.
42. Kang SH, Park JW, Yoon KW, Do JY. Limb/trunk lean mass ratio as a risk factor for mortality in peritoneal dialysis patients. J Renal Nutr 2013; 23:315-323.
43. Isoyama N, Qureshi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 2014; 9:1720-1728.
44. Lamarca F, Carrero JJ, Rodrigues JC, et al. Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging 2014; 18:710-717.
45. Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage renal disease. J Am Soc Nephrol 2013; 24:337-351.
46. Wilson FP, Xie D, Anderson AH, et al. Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol 2014; 9:2095-2103.
47. Morishita Y, Kubo K, Miki A, et al. Positive association of vigorous and moderate physical activity volumes with skeletal muscle mass but not bone density or metabolism markers in hemodialysis patients. Int Urol Nephrol 2014; 46:633-639.
48. Mihaescu A, Avram C, Bob F, et al. Benefits of exercise training during hemodialysis sessions: a prospective cohort study. Nephron Clin Pract 2013; 124:72-78.
49. Moraes C, Leal VO, Marinho SM, et al. Resistance exercise training does not affect plasma irisin levels in hemodialysis patients. Horm Metab Res 2013; 45:900-904.
50. Kirkman DL, Mullins P, Junglee NA, et al. Anabolic exercise in haemodialysis patients: a randomised controlled pilot study. J Cachexia Sarcopenia Muscle 2014; 5:199-207.
51. Johansen KL, Painter PL, Sakkas GK, et al. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized controlled trial. J Am Soc Nephrol 2006; 17:2307-2314.
52. Segura-Orti E, Kouidi E, Lison JF. Effect of resistance exercise during hemodialysis on physical function and quality of life: randomized controlled trial. Clin Nephrol 2009; 71:527-537.
53. Cheema B, Abas H, Smith B, et al. Progressive exercise for anabolism in kidney disease (PEAK): a randomized controlled trial of resistance training during hemodialysis. J Am Soc Nephrol 2007; 18:1594-1601.
54. Baria F, Kamimura MA, Aoike DT, et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight kidney disease patients. Nephrol Dial Transplant 2014; 29:857-864.
55. Magnard J, Deschamps T, Cornu C, et al. Effects of a six-month intradialytic physical ACTIvity program and adequate NUTritional support on proteinenergy wasting, physical functioning and quality of life in chronic hemodialysis patients: ACTINUT study protocol for a randomised controlled trial. BMC Nephrol 2013; 14:259.
56. Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA 1999; 281:1275-1281.
57. Macdonald JH, Marcora SM, Jibani MM, et al. Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dosefinding study. Nephron Clin Pract 2007; 106:c125-c135.
58. Bello AK, Stenvinkel P, Lin M, et al. Serum testosterone levels and clinical outcomes in male hemodialysis patients. Am J Kidney Dis 2014; 63:268-275.
59. Kojo G, Yoshida T, Ohkawa S, et al. Association of serum total testosterone concentration with skeletal muscle mass in men under hemodialysis. Int Urol Nephrol 2014; 46:985-991.
60. Cigarran S, Pousa M, Castro MJ, et al. Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease. J Ren Nutr 2013; 23:e89-e95.
61. Supasyndh O, Satirapoj B, Aramwit P, et al. Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients. Clin J Am Soc Nephrol 2013; 8:271-279.